Covered recipient · General Payments record
SHRUTI A FADIA
Allopathic & Osteopathic Physicians Pediatrics Pediatric Endocrinology
General Payments · PY2018–2024
$949.78
- Reported across 27 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $546.37 | 11 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| SANOFI-AVENTIS U.S. LLC | $330.91 | 3 |
| Abbott Laboratories | $48.43 | 1 |
| Insulet Corporation | $42.13 | 1 |
| Kyowa Kirin, Inc. | $25.33 | 1 |
| Ascendis Pharma Inc | $23.00 | 1 |
| Eton Pharmaceuticals, Inc. | $22.73 | 1 |
| BETA BIONICS, INC. | $19.23 | 1 |
| Novo Nordisk AS | $17.31 | 1 |
| Tandem Diabetes Care, Inc. | $17.30 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (11)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $48.43 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125180640 | CMS |
| Ascendis Pharma Inc | $23.00 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133847046 | CMS |
| BETA BIONICS, INC. | $19.23 | 04/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087875045 | CMS |
| Eton Pharmaceuticals, Inc. | $22.73 | 06/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108021252 | CMS |
| Insulet Corporation | $42.13 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116803828 | CMS |
| Kyowa Kirin, Inc. | $25.33 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1127043175 | CMS |
| Novo Nordisk Inc | $17.31 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096609010 | CMS |
| SANOFI-AVENTIS U.S. LLC | $114.82 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139929025 | CMS |
| SANOFI-AVENTIS U.S. LLC | $107.35 | 05/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139929027 | CMS |
| SANOFI-AVENTIS U.S. LLC | $108.74 | 06/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139929083 | CMS |
| Tandem Diabetes Care, Inc. | $17.30 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138750753 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.